Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 282-784-6 | CAS number: 84418-71-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://poisoncentres.echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Description of key information
Repeated oral dose toxicity combined to a reproduction screening (OECD guideline 422) in SD rats:
-The No Observed Adverse Effect Level (NOAEL) for parental systemic toxicity was considered to be 300 g/kg/day based on absence of adverse findings at this high-dose level,
- The No Observed Adverse Effect Level (NOAEL) for local tolerance was considered to be lower than 30 mg/kg/day (pronounced microscopic changes in the forestomach in males from 30 mg/kg/day and in females from 100 mg/kg/day).
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Link to relevant study records
- Endpoint:
- short-term repeated dose toxicity: oral
- Remarks:
- combined repeated dose and reproduction / developmental screening
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From August 2013 to 27 January 2014.
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study was conducetd according to international test guidelines and to GLP.
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
- Deviations:
- yes
- Remarks:
- : the estrous cycle stage was not determined on the third day of the mating period for one control female, due to an oversight. This deviation was considered not to have compromised the validity or integrity of the study.
- Principles of method if other than guideline:
- Not applicable.
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France.
- Age at study initiation: males were approximately 10 weeks old and the females were approximately 9 weeks old.
- Weight at study initiation: males had a mean body weight of 408 g (range: 367 g to 449 g) and the females had a mean body weight of of 225 g (range: 208 g to 252 g).
- Fasting period before study: no
- Housing: the animals were individually housed, except during pairing and lactation, in polycarbonate cages (Tecniplast 2154, 940 cm²) with stainless steel lids and containing autoclaved sawdust (SICSA, Alfortville, France). Individual housing was chosen since it is preferable for pregnant animals and mating purpose.
Toward the end of gestation and during lactation, autoclaved wood shavings (SICSA, Alfortville, France) were provided to females and their litter as nesting material.
- Diet (e.g. ad libitum): SSNIFF R/M-H pelleted maintenance diet, batch Nos. 3833086 and 1229567 (SSNIFF Spezialdiäten GmbH, Soest, Germany)
- Water (e.g. ad libitum): tap water (filtered with a 0.22 µm filter).
- Acclimation period: 7 days before the beginning of the treatment period. A larger number of animals than necessary were acclimated to permit the selection and/or replacement of individuals.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2°C
- Humidity (%): 50 ± 20%
- Air changes (per hr): about 12 cycles/hour of filtered, non-recycled air.
- Photoperiod (hrs dark / hrs light): 12h/12h.
IN-LIFE DATES: From: 3 September 2013 to 03 November 2013. - Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Remarks:
- (batch Nos. MKBH4894V and MKBP7039V).
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
The test item dose formulations were prepared daily and delivered to the study room at room temperature and protected from light. No correction factor was applied for the dose calculations.
VEHICLE
- Amount of vehicle (if gavage): 5 mL/kg bw/day
- Lot/batch no. (if required): MKBH4894V and MKBP7039V.
- Purity: no data - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Concentrations of the test item in the dose formulations have been quantified by a validated Ion Chromatography (IC) with conductivity detection analytical method.
The validation of the analytical method was conducted in CiToxLAB France/Study No. 40285 VAA and precise details concerning the checked parameters, acceptance criteria and obtained results are documented in the corresponding validation report. - Duration of treatment / exposure:
- In the males:
- 2 weeks before mating (from study day 1 to 14)
- during the mating period (from study day 15 until study day 16 to 19),
- until sacrifice (at least 5 weeks in total) (from study day 17 to 20 until study day 36).
In the females:
- 2 weeks before mating (from study day 1 to 14),
- during the mating period (from study day 15 until study day 16 to 19),
- during gestation (from study day 16 to 19 until study day 36 to 40),
- during lactation until day 5 p.p. inclusive (from study day 37 to 41 until study day 42 to 46),
- until sacrifice for the non-pregnant female (until study day 42).
Day 1 corresponds to the first day of the treatment period. - Frequency of treatment:
- Once daily, at approximately the same time (7 days/week)
- Remarks:
- Doses / Concentrations:
0, 30, 100 or 300 mg/kg bw/day.
Basis:
other: nominal concentration. - No. of animals per sex per dose:
- 10 animals/sex/dose.
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- Dose selection rationale: the dose-levels were set based on the results of a previous 2-week dose-range finding study performed in the same species and strain (CiToxLAB France/Study No. 40287 TSR). ). In this study, 4 groups of 3 males and 3 females received 0 (corn oil), 100, 400 or 1000 mg/kg/day daily for 2 weeks by gavage with a constant dose volume of 5 mL/kg/day. In this preliminary study, there were the following findings:
- clinical signs: ptyalism (hypersalivation) from 400 mg/kg/day (from study day 3 or 8) in both sexes,
- body weight and food consumption: no obvious effects (high variations between animals),
- macroscopic examination at necropsy: no effects on mean organ weight, but thickened and/or white discoloration of forestomach from 400 mg/kg (1 to 3 animals per sex).
Ptyalism was considered to be test item treatment-related but of minor toxicological significance. However, the effects on forestomach were considered to represent signs of local intolerance to the test item and potentially related to its corrosive properties. Therefore, 300 mg/kg/day was selected as the high-dose level. The low-dose and mid-dose were selected using a ratio representing approximately a 3-fold interval (i.e. 30 and 100 mg/kg/day).
- Rationale for animal assignment (if not random): during the acclimation period, the required number of animals (40 males and 40 females) was selected according to body weight and clinical condition. The animals were allocated to groups (by sex) using a computerized stratification procedure based on body weight, so that the average body weight of each group was similar. - Positive control:
- Not used.
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: each animal was checked for mortality or signs of morbidity once a day before the treatment period and at least twice a day during the treatment period, including weekends and public holidays. From arrival, each animal was observed once a day as part of routine examinations. From the start of the treatment period, each animal was observed once a day, at approximately the same time, for the recording of clinical signs.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: detailed clinical examinations were performed on all animals once before the beginning of the treatment period and then once a week until the end of the study.
Observations included (but were not limited to) changes in the skin, fur, eyes, mucous membranes, occurrence of secretions and excretions and autonomic activity (e.g. lachrymation, piloerection, pupil size, unusual respiratory pattern). Changes in gait, posture and response to handling as well as the presence of clonic or tonic movements, stereotypes (e.g. excessive grooming, repetitive circling) or bizarre behavior (e.g. self mutilation, walking backwards) were also recorded.
BODY WEIGHT: Yes
- Time schedule for examinations: the body weight of each male was recorded on the first day of treatment (day 1), then once a week until sacrifice.
The body weight of each female was recorded on the first day of treatment (day 1), then once a week until mated and on days 0, 7, 14 and 20 post-coitum (p.c.) and days 1 and 5 p.p..
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study):
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
The quantity of food consumed by each male was measured once a week, over a 7 day period, from the first day of treatment until the start of the mating period. The quantity of food consumed by each female was measured once a week, over a 7 day period, from the first day of treatment until the start of the mating period, during pregnancy at the intervals days 0-7, 7 14 and 14-20 p.c. and during lactation for interval days 1 5 p.p.. During the mating period, food consumption was not measured for males or females.
Food intake per animal and per day was calculated by noting the difference between the food given and that in the food-hopper the next time.
HAEMATOLOGY: Yes
- Time schedule for collection of blood: at the end of the study.
- Anaesthetic used for blood collection: Yes (light isoflurane)
- Animals fasted: Yes
- How many animals: the first five males and the first five females to be sacrificed on Day 6 p.p. from each group on the day of scheduled sacrifice.
- The following parameters were determined: Erythrocytes (RBC), Mean cell volume (MCV), Packed cell volume (PCV), Hemoglobin (HB), Mean cell hemoglobin concentration (MCHC),Thrombocytes (PLT), Leucocytes (WBC), Differential white cell count with cell morphology (Neutrophils (N), eosinophils (E), basophils (B), lymphocytes and large unstained cells (L+LUC) and monocytes (M)) and Reticulocytes (RTC).
Coagulation: Prothrombin time (PT) + Fibrinogen (FIB) + Activated partial thromboplastin time (APTT).
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood: at the end of the study.
- Animals fasted: Yes
- How many animals: the first five males and the first five females to be sacrificed on Day 6 p.p. from each group on the day of scheduled sacrifice.
- Parameters (examined): Sodium (Na+), Potassium (K+), Chloride (Cl-), Calcium (Ca++), Inorganic phosphorus (I.PHOS), Glucose (GLUC), Urea (UREA), Creatinine (CREAT), Total bilirubin (TOT.BIL.), Total cholesterol (CHOL), Triglycerides (TRIG), Alkaline phosphatase (ALP), Alanine
aminotransferase (ALAT), Aspartate aminotransferase (ASAT), Total proteins (PROT), Albumin (ALB) and Albumin/globulin ratio (A/G).
URINALYSIS: Yes
- Time schedule for collection of urine: at the end of the study.
- Metabolism cages used for collection of urine: Yes
- Animals fasted: Yes
- Parameters (examined):
1- Quantitative parameters: volume (Volume), pH (pH) and Specific gravity (SP.GRAV).
2- Semi-quantitative parameters: Proteins (PROT), Glucose (GLUC), Ketones (CETO), Bilirubin (BILI), Nitrites (NITR), Blood (hemoglobin) (BLOOD), Urobilinogen (UROB) and Cytology of sediment (leucocytes (WBC), erythrocytes (RBC), cylinders (CYLIN), magnesium ammonium phosphate crystals (AMM.PH), calcium phosphate crystals (CAL.PH), calcium oxalate crystals (CAL.OX.), epithelial cells (CELLS))
3- Qualitative parameters: Appearance (APP) and Color (COLOR).
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations: at the end of the treatment period. For females, this was performed on day 5 p.p. after sacrifice of the pups.
- Dose groups that were examined: the first five males and the first five females to be sacrificed on day 6 p.p. from each group were evaluated
- Battery of functions tested: touch response, forelimb grip strength, pupillary reflex, visual stimulus response, auditory startle reflex, tail pinch response, righting reflex, landing foot splay and at the end of observation: rectal temperature. - Sacrifice and pathology:
- GROSS PATHOLOGY: Yes
A macroscopic post-mortem examination of the principal thoracic and abdominal organs was performed on all F0 animals. This included examination of the external surfaces, all orifices, the cranial cavity, the external surfaces of the brain and spinal cord, the thoracic, abdominal and pelvic cavities with their associated organs and tissues and the neck with its associated organs and tissues. Special attention was paid to the reproductive organs. The numbers of corpora lutea and implantation sites were also recorded for females sacrificed as scheduled on Day 6 p.p. and for females sacrificed on Days 25 or 26 p.c. due to no delivery. For apparently non-pregnant female the presence of implantation scars on the uterus was checked.
HISTOPATHOLOGY / ORGAN WEIGHTS
A microscopic examination was performed on:
- all tissues listed in the Tissue Procedure Table (See Table 7.5.1/1) from the first five sacrificed as scheduled males and the first five females sacrificed on day 6 p.p. of the control and high-dose groups (groups 1 and 4),
- all macroscopic lesions of all groups.
Special emphasis was paid to the stages of spermatogenesis in the male gonads and histopathology of interstitial testicular cell structure.
ORGAN WEIGHTS: the body weight of each animal sacrificed as scheduled after the end of the mating period for males or on Day 6 p.p. for females was recorded before sacrifice and the organs specified in the Tissue Procedure Table (See Table 7.5.1/1) were weighed (wet) as soon as possible after dissection. - Other examinations:
- See "Tox.reproOECD 422 study V1 CiToxLAB 2013" section
- Statistics:
- The following statistical methods were used to analyze body weights, food consumption, reproduction and skeletal examination data:
• Means and standard deviations of various data were calculated.
• If the variables could be assumed to follow a normal distribution, the Dunnett t-test, based on a pooled variance estimate, was used for inter-group comparisons (i.e. single treatment groups against the control group).
• The Steel test (rank test) was applied when the data could not be assumed to follow a normal distribution.
• Fisher's Exact test for 2x2 tables was applied if the variables could be dichotomized without loss of information. - Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- considered to be of minor toxicological importance.
- Mortality:
- mortality observed, treatment-related
- Description (incidence):
- considered to be of minor toxicological importance.
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Ophthalmological findings:
- not examined
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- effects observed, treatment-related
- Description (incidence and severity):
- see details on results section
- Gross pathological findings:
- effects observed, treatment-related
- Description (incidence and severity):
- see details on results section
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- see details on results section
- Histopathological findings: neoplastic:
- not examined
- Details on results:
- CLINICAL SIGNS AND MORTALITY
There were no unscheduled deaths in males during the study.
For no delivery, one female given 30 mg/kg/day was sacrificed on Day 26 p.c. and two others given 100 mg/kg/day were sacrificed on Day 25 p.c.. These females were found to be non-pregnant at necropsy.
Ptyalism was recorded in 6/10 males given 100 mg/kg/day and in all males and females given 300 mg/kg/day throughout the premating, gestation and/or lactation periods. This sign, commonly observed when a test item is administered by gavage, was considered to be of minor toxicological importance.
Other findings (area(s) of hair loss and cutaneous lesion(s) on neck), commonly observed in this species and strain, were considered to be not treatment related
BODY WEIGHT AND WEIGHT GAIN
There were no effects on mean body weight and mean body weight change in males and females during the study.
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study)
There were no effects on mean food consumption during the study in males and females.
HAEMATOLOGY
There were no test item-related effects and no statistically significant changes in mean hematology and coagulation data (See Table 7.5.1/2)
CLINICAL CHEMISTRY
There were no test item-related effects on mean blood biochemistry data (See Table 7.5.1/3)
URINALYSIS
No relevant differences were noted in the quantitative or qualitative urinary parameters between control and test item-treated animals.
NEUROBEHAVIOUR
There were no differences between test item-treated and control groups in motor activity (horizontal movements and rearing). There were no behaviral or neurologic abnormalities in any animal.
ORGAN WEIGHTS
When compared with controls, the following changes in the mean organ weights were observed:
- the absolute and relative liver weights were higher in males given 300 mg/kg/day but without reaching a statistical significance,
- the absolute and relative spleen weights were higher in males given 30 or 100 mg/kg/day reaching a statistical significance for the absolute weight at 100 mg/kg/day (p<0.05). In the absence of a similar trend at 300 mg/kg/day, any relationship with the test item was excluded,
- the absolute and relative adrenal weights were higher in males given 30 mg/kg/day without reaching a statistical significance. In the absence of a similar trend at 100 or 300 mg/kg/day, any relationship with the test item was excluded.
Other changes in the mean organ weights were considered to be part of the normal variation between groups.
GROSS PATHOLOGY
Thickening or white discoloration of the forestomach was seen in 1/10 males given 30 mg/kg/day, 1/10 males given 100 mg/kg/day, 9/10 males and 2/10 females given 300 mg/kg/day. This mainly correlated histologically with hyperplasia of squamous cells and/or hyperkeratosis and was considered to be related to the test item.
Black deposit was present in the stomach of one female given 100 mg/kg/day correlating histologically with erosion and one female given 300 mg/kg/day correlating with a chronic inflammation of the serosa with fibrosis. This stomach also appeared thickened. Any relationship with the test item was excluded.
Reduced size of testes was observed bilaterally in one male given 100 mg/kg/day (associated with reduced size of epididymides) and unilaterally in one male given 300 mg/kg/day (associated with agenesis of the epididymis). These isolated changes were considered to be fortuitous and without relationship with the test item.
Other macroscopic changes were considered to be part of the normal changes commonly seen in rats and were considered without any relationship with the test item.
HISTOPATHOLOGY
Test item-related changes were seen in the forestomach at all dose-levels in males and at 100 or 300 mg/kg/day in females.
1- Forestomach:
The forestomach was examined histologically in the following animals:
- the first five sacrificed as scheduled males from all groups 1 to 4 (controls, 30, 100 and 300 mg/kg/day respectively) and those showing macroscopic changes at necropsy (one given 30 mg/kg/day and four given 300 mg/kg/day),
- the first five females sacrificed on Day 6 post-partum from groups 1 to 4 (controls, 30, 100 and 300 mg/kg/day respectively).
Hyperplasia of squamous cells (graded minimal to marked in males and minimal to moderate in females) was observed at all dose-levels in males and at 100 and 300 mg/kg/day in females. This was often associated with hyperkeratosis. Additional changes consisted of minimal erosion/ulceration in a few animals at 100 and 300 mg/kg/day and inflammation and/or edema
2- Miscellaneous:
Minimal mononuclear cell infiltrate (perivascular) was observed in lungs of all groups including controls, but with a higher incidence in treated animals than in controls. However, in the absence of a dose-related incidence and/or severity any relationship with the test item was excluded.
3- Testes:
Marked tubular atrophy was seen in the right testis of one male given 300 mg/kg/day correlating with the reduced size noted at necropsy.
Severe tubular atrophy was seen bilaterally in one male given 100 mg/kg/day associated with severe reduced sperm count in the epididymides correlating with the reduced size observed at necropsy.
As these changes are occasionally seen in rats, involved only one side in the high dose group male and in the absence of testes changes in the other treated animals, these isolated observations were considered to be fortuitous.
4- Liver
There were no histopathological correlates with the higher liver weight at necropsy in males at 300 mg/kg/day. - Dose descriptor:
- NOAEL
- Remarks:
- (systemic toxicity)
- Effect level:
- 300 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: based on absence of adverse findings at this high-dose level.
- Dose descriptor:
- NOAEL
- Remarks:
- (local toxicity)
- Effect level:
- < 30 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: based on pronounced microscopic changes in the forestomach in males from 30 mg/kg bw/day and in females from 100 mg/kg bw/day.
- Critical effects observed:
- not specified
- Conclusions:
- Under the test conditions of this study, the No Observed Adverse Effect Level (NOAEL) for systemic toxicity was considered to be 300 mg/kg bw/day based on absence of adverse findings at this high-dose level and the NOAEL for local tolerance was considered to be lower than 30 mg/kg bw/day based on pronounced microscopic changes in the forestomach in males from 30 mg/kg bw/day and in females from 100 mg/kg bw/day.
- Executive summary:
A combined repeated dose toxicity study with the reproduction/developmental toxicity screening test (CiToxLAB, 2013) was conducted with Phosphoric acid, mono and bis(branched and linear pentyl)esters according to the OECD test guideline No. 422 and in compliance with GLP.
Sprague-Dawley rats (10/sex/dose level) received the test item daily by oral (gavage) administration before mating, through mating and, for the females, through gestation until day 5 p.p.. The test item was administered at dose levels of 30, 100 and 300 mg/kg/day in the vehicle (Corn oil). Another group of ten males and ten females received the vehicle, alone, under the same experimental conditions and acted as a control group. A constant dosage volume of 5 mL/kg bw/day was used.
The animals were checked daily for clinical signs, mortality, and detailed clinical observations were conducted weekly. Body weight and food consumption were recorded weekly until mating and then at designated intervals throughout gestation and lactation. A Functional Observation Battery (FOB), including motor activity, and laboratory investigations (haematology, blood biochemistry and urinalysis) were carried out on five males and five females from each group at the end of the study.
The males were sacrificed after completion of the mating period and dams were sacrificed on Day 6 p.p.. A full macroscopic post mortem examination was performed, with particular attention accorded to the reproductive organs. Designated organs were weighed and selected tissue specimens were preserved.
A microscopic examination was performed on selected organs from the first five males sacrificed at the end of the treatment period and the first five females sacrificed on Day 6 p.p. of the control and high-dose groups and on all macroscopic lesions from all groups.
A macroscopic post-mortem examination of the principal thoracic and abdominal organs was performed on pups sacrificed on Day 5 p.p. and on those found dead.
There were no unscheduled test item-related deaths. Ptyalism was the only recorded clinical sign, observed in both sexes at 300 mg/kg/day and in males at 100 mg/kg/day. This finding was considered to be related to the test item but of minor toxicological importance. There were no effects on body weight, food consumption, functional observation battery tests or motor activity data in any group and sex. No relevant changes were noted in haematology and biochemistry parameters. At pathology examination, microscopic changes were seen in the forestomach at all dose-levels in males and at 100 and 300 mg/kg/day in females. These included erosions (at 100 and 300 mg/kg), hyperplasia of squamous cells with hyperkeratosis (correlating with macroscopy), inflammation and edema. Due to the severity of these changes and the presence of erosion/ulcer at 100 and 300 mg/kg/day, these changes were considered to be adverse at both these levels in rats. Despite the absence of histopathological correlates, the higher liver weight in males at 300 mg/kg/day was considered to be test item-related but non adverse.
Based on the experimental conditions of this study:
-The No Observed Adverse Effect Level (NOAEL) for parental systemic toxicity was considered to be 300 g/kg/day based on absence of adverse findings at this high-dose level,
- The No Observed Adverse Effect Level (NOAEL) for local tolerance was considered to be lower than 30 mg/kg/day (pronounced microscopic changes in the forestomach in males from 30 mg/kg/day and in females from 100 mg/kg/day).
This study is considered as acceptable as it satisfies the main criteria of OECD guideline No.422.
Reference
Table 7.5.1/2: Most hematology findings (the Table below presents the statistically differences when compared with control values)
|
Hematology |
|||||||
Sex |
Male |
Female |
||||||
Dose-level (mg/kg/day) |
0 |
30 |
100 |
300 |
0 |
30 |
100 |
300 |
Erythrocytes (T/L) |
9.65 |
6.59 |
3.26 |
8.82 |
7.24 |
7.88* |
7.82 |
7.64 |
Packed cell volume (L/L) |
0.53 |
0.51 |
0.51 |
0.19* |
0.44 |
0.46 |
0.44 |
0.45 |
Mean cell volume (L/L) |
54.7 |
53.6 |
54.9 |
55.6 |
60.3 |
58.7 |
56.7* |
58.8 |
Mean cell hemoglobin (fL) |
17.3 |
17.3 |
17.5 |
18.0 |
19.8 |
19.2 |
16.6* |
19.3 |
Mean cell hemoglobin concentration (g/dL) |
31.6 |
32.3 |
31.8 |
32.3* |
32.8 |
32.8 |
32.8 |
32.8 |
Statistically significant: *: p<0.05.
Table 7.5.1/3: Most blood biochemistry findings (the Table below presents the statistically differences when compared with control values)
|
Blood biochemistry |
|||||||
Sex |
Male |
Female |
||||||
Dose-level (mg/kg/day) |
0 |
30 |
100 |
300 |
0 |
30 |
100 |
300 |
Calcium (mmol/L) |
2.64 |
2.62 |
2.65 |
2.63 |
2.62 |
2.63 |
2.68 |
2.74* |
Alkaline phosphatase (IU/L) |
335 |
270 |
325 |
250* |
164 |
189 |
144 |
129 |
Alanine aminotransferase (IU/L) |
37 |
39 |
43* |
37 |
57 |
58 |
59 |
59 |
Statistically significant: *: p<0.05.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- NOAEL
- 300 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rat
- Quality of whole database:
- The key study is reliable (Klimisch reliability: 1). This study is performed according to OECD Guideline N° 422 and in compliance with GLP.
Repeated dose toxicity: inhalation - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: inhalation - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Repeated dose toxicity: dermal - local effects
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Repeated dose toxicity via oral route:
One study of reliability 1 according to Klimisch cotation critera, is available (CiToxLAB, 2013) and was selected as a key study.In this study (OECD 422), Sprague-Dawley rats (10/sex/dose level) received the test item daily by oral (gavage) administration before mating, through mating and, for the females, through gestation until day 5 p.p.. The test item was administered at dose levels of 30, 100 and 300 mg/kg/day in the vehicle (Corn oil). Another group of ten males and ten females received the vehicle, alone, under the same experimental conditions and acted as a control group.
The animals were checked daily for clinical signs, mortality, and detailed clinical observations were conducted weekly. Body weight and food consumption were recorded weekly until mating and then at designated intervals throughout gestation and lactation. A Functional Observation Battery (FOB), including motor activity, and laboratory investigations (haematology, blood biochemistry and urinalysis) were carried out on five males and five females from each group at the end of the study.
There were no unscheduled test item-related deaths. Ptyalism was the only recorded clinical sign, observed in both sexes at 300 mg/kg/day and in males at 100 mg/kg/day. This finding was considered to be related to the test item but of minor toxicological importance. There were no effects on body weight, food consumption, functional observation battery tests or motor activity data in any group and sex. No relevant changes were noted in haematology and biochemistry parameters. At pathology examination, microscopic changes were seen in the forestomach at all dose-levels in males and at 100 and 300 mg/kg/day in females. These included erosions (at 100 and 300 mg/kg), hyperplasia of squamous cells with hyperkeratosis (correlating with macroscopy), inflammation and edema. Due to the severity of these changes and the presence of erosion/ulcer at 100 and 300 mg/kg/day, these changes were considered to be adverse at both these levels in rats.
Based on the experimental conditions of this study:
-The No Observed Adverse Effect Level (NOAEL) for parental systemic toxicity was considered to be 300 g/kg/day based on absence of adverse findings at this high-dose level,
- The No Observed Adverse Effect Level (NOAEL) for local tolerance was considered to be lower than 30 mg/kg/day (pronounced microscopic changes in the forestomach in males from 30 mg/kg/day and in females from 100 mg/kg/day).
Justification for selection of repeated dose toxicity via oral route - systemic effects endpoint:
Only one study was available.
Justification for classification or non-classification
Based on the available data (OECD 422 results), Phosphoric acid, mono and bis(branched and linear pentyl)esters is not classified for repeated dose toxicity according to the criteria of the Regulation (EC) No 1272/2008 and the Directive 67/548/EEC criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)